Gilead Sciences ' net income amounted to nearly 5.4 billion U.S. dollars in 2019 . The statistic illustrates Gilead Sciences ' net income from 2006 to 2019 . The company shot to the public spotlight in the first quarter of 2020 for its drug remdesivir , which was trialed against COVID-19 .
